Details for Patent: 11,793,796
✉ Email this page to a colleague
Which drugs does patent 11,793,796 protect, and when does it expire?
Patent 11,793,796 protects ZORYVE and is included in two NDAs.
This patent has thirty-one patent family members in twelve countries.
Drugs Protected by US Patent 11,793,796
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Arcutis | ZORYVE | roflumilast | CREAM;TOPICAL | 215985-001 | Jul 29, 2022 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
| Arcutis | ZORYVE | roflumilast | FOAM;TOPICAL | 217242-001 | Dec 15, 2023 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,793,796
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2018282098 | ⤷ Try a Trial | |||
| Australia | 2021214399 | ⤷ Try a Trial | |||
| Brazil | 112019025748 | ⤷ Try a Trial | |||
| Brazil | 112022015104 | ⤷ Try a Trial | |||
| Canada | 3006836 | ⤷ Try a Trial | |||
| Canada | 3166300 | ⤷ Try a Trial | |||
| China | 108992673 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
